Sofinnova Management IX, L.L.C.
Insider CIK 1612134 · LIFE 10% owner · GRTX 10% owner · CMPI 10% owner · ITRM 10% owner · NXTC 10% owner · ETTX 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CMPI Checkmate Pharmaceuticals, | C Conversion deriv | 2020-08-11 | 2020-08-12 | 12,500,000 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | C Conversion deriv | 2020-08-11 | 2020-08-12 | 8,753,350 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | C Conversion deriv | 2020-08-11 | 2020-08-12 | 3,644,624 | — | $0 | 0 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | C Conversion | 2020-08-11 | 2020-08-12 | 3,473,374 | — | $0 | 3,473,374 | SEC↗ |
| CMPI Checkmate Pharmaceuticals, | P Buy | 2020-08-11 | 2020-08-12 | 133,333 | $15.00 | $2.00M | 3,606,707 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2020-06-02 | 2020-06-03 | 400,000 | $1.61 | $644.0K | 1,226,514 | SEC↗ |
| ITRM Iterum Therapeutics plc | S Sale | 2020-06-01 | 2020-06-03 | 100,000 | $1.69 | $169.0K | 1,626,514 | SEC↗ |
| ITRM Iterum Therapeutics plc | A Award deriv | 2020-01-21 | 2020-01-23 | 0 | $1750000.00 | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2019-11-15 | 2019-11-19 | 150,000 | $36.75 | $5.51M | 2,671,856 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 9,090,909 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion deriv | 2019-11-12 | 2019-11-12 | 2,709,659 | — | $0 | 0 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | P Buy | 2019-11-12 | 2019-11-12 | 750,000 | $12.00 | $9.00M | 3,083,712 | SEC↗ |
| GRTX Galera Therapeutics, Inc. | C Conversion | 2019-11-12 | 2019-11-12 | 2,333,712 | — | $0 | 2,333,712 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 3,773,585 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 7,301,000 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 3,732,500 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion deriv | 2019-05-13 | 2019-05-15 | 2,239,500 | — | $0 | 0 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 464,599 | — | $0 | 743,358 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 908,785 | — | $0 | 1,652,143 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 469,713 | — | $0 | 2,121,856 | SEC↗ |
| NXTC NextCure, Inc. | C Conversion | 2019-05-13 | 2019-05-15 | 278,759 | — | $0 | 278,759 | SEC↗ |
| NXTC NextCure, Inc. | P Buy | 2019-05-13 | 2019-05-15 | 400,000 | $15.00 | $6.00M | 2,521,856 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 7,446,904 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion deriv | 2018-09-28 | 2018-10-02 | 9,502,249 | — | $0 | 0 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 359,267 | — | $0 | 359,267 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | P Buy | 2018-09-28 | 2018-10-02 | 337,724 | $15.00 | $5.07M | 1,180,178 | SEC↗ |
| ETTX Entasis Therapeutics Holdi | C Conversion | 2018-09-28 | 2018-10-02 | 458,425 | — | $0 | 842,454 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 721,408 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 229,660 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion deriv | 2018-05-30 | 2018-05-30 | 275,446 | — | $0 | 0 | SEC↗ |
| ITRM Iterum Therapeutics plc | P Buy | 2018-05-30 | 2018-05-30 | 500,000 | $13.00 | $6.50M | 1,726,514 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 721,408 | — | $0 | 721,408 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 229,660 | — | $0 | 1,226,514 | SEC↗ |
| ITRM Iterum Therapeutics plc | C Conversion | 2018-05-30 | 2018-05-30 | 275,446 | — | $0 | 996,854 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion deriv | 2015-05-12 | 2015-05-14 | 14,968,722 | — | $0 | 0 | SEC↗ |
| LIFE aTYR PHARMA INC | C Conversion | 2015-05-12 | 2015-05-14 | 1,546,126 | — | $0 | 1,546,126 | SEC↗ |
| LIFE aTYR PHARMA INC | P Buy | 2015-05-12 | 2015-05-14 | 320,000 | $14.00 | $4.48M | 1,866,126 | SEC↗ |